All In Biotech

Drug Trial Radar · NCT04740840

Anti Inflammatory Treatment of Hypertension

Comparison of Anti-inflammatory Effects of Amlodipine and Levamlodipine in Patients With Hypertension

Last checked: Nov 19, 2026Latest source record: Feb 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

200

Actual

Start

May 1, 2010

Primary completion

Apr 2, 2012

Study completion May 2, 2015

Sponsor

Lead sponsor
Affiliated Hospital of North Sichuan Medical CollegeAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
First Hospitals affiliated to the China PLA General Hospital
First posted
Feb 5, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To investigate the anti-inflammatory effect of amlodipine and levamlodipine in the treatment of hypertension

Conditions

  • Hypertension

Interventions

  • LevamlodipineDrug

    According to the inclusion criteria of the trial, those who met the diagnosis of hypertension were randomly divided into the experimental group and the control group. The experimental group was treated with 2.5mg levamlodipine to lower blood pressure. Abdominal blood was emptying before the start of the trial and at the first and third month of medication.Data on CRP, TNF-α, IL-6, Lp-PLA2 and ATP were collected.

  • AmlodipineDrug

    According to the inclusion criteria, patients who met the diagnosis of hypertension were randomly divided into the experimental group and the control group. The experimental group was given 5mg amlodipine to lower blood pressure. Fasting blood was collected before the trial and during the first and third months of treatment. CRP, TNF-α, IL-6, Lp-PLA2 and ATP data were collected.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. After treatment, the blood pressure control of L-amlodipine group was better than that of amlodipine groupTime frame: One month after treatment
  2. the serum inflammatory factor level of L-amlodipine group was lower than that of amlodipine groupTime frame: One month after treatment
  3. Serum ATP level can be used to evaluate the anti-inflammatory effect of hypertension drugsTime frame: One month after treatment

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.